Replimune (REPL) Cash from Investing Activities (2017 - 2026)
Replimune's Cash from Investing Activities was $49.99 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 23.1% from $65.05 million a year earlier and down 42.2% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Cash from Investing Activities (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Replimune's Cash from Investing Activities was $295.79 million through Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at $310.84 million.
- In earlier fiscal years, Cash from Investing Activities was -$23.8 million in FY2025, $97.2 million in FY2024, -$142.5 million in FY2023 and -$1.81 million in FY2022.
- The fiscal Q1 2027 figure marks the lowest quarterly Cash from Investing Activities since fiscal Q4 2025.
- Per Business Quant data, REPL's Cash from Investing Activities in the three fiscal quarters before Q1 2027 was $86.51 million (Q4 2026), $75.12 million (Q3 2026) and $84.17 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Replimune | 1.13 Bn | 1.13 Bn | - | 49.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.99 Mn |
| Mar 31, 2026 | 86.51 Mn |
| Dec 31, 2025 | 75.12 Mn |
| Sep 30, 2025 | 84.17 Mn |
| Jun 30, 2025 | 65.05 Mn |
| Mar 31, 2025 | -7.70 Mn |
| Dec 31, 2024 | -46.32 Mn |
| Sep 30, 2024 | 458,000.00 |
| Jun 30, 2024 | 29.77 Mn |
| Mar 31, 2024 | 23.20 Mn |
| Dec 31, 2023 | 53.96 Mn |
| Sep 30, 2023 | 12.68 Mn |
| Jun 30, 2023 | 7.36 Mn |
| Mar 31, 2023 | -22.75 Mn |
| Dec 31, 2022 | -125.10 Mn |
| Sep 30, 2022 | 36,000.00 |
| Jun 30, 2022 | 5.32 Mn |
| Mar 31, 2022 | -4.33 Mn |
| Dec 31, 2021 | -13.42 Mn |
| Sep 30, 2021 | -11.05 Mn |
API Access
Replimune Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();